HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ICCVAM To Study Alternative Animal Test Feasibility For Ocular Irritation

This article was originally published in The Rose Sheet

Executive Summary

The Interagency Coordinating Committee on the Validation of Alternative Methods will review four non-animal in vitro tests this year to assess whether they are predictive in identifying severe ocular irritants and corrosives, according to the group
Advertisement

Related Content

Ocular Irritation Assay Data Deemed Incomplete By ICCVAM Panel
Ocular Irritation Assay Data Deemed Incomplete By ICCVAM Panel
Ocular Irritation Test Recommendations Outlined By ICCVAM
Ocular Irritation Test Recommendations Outlined By ICCVAM
Ocular irritation tests
Ocular irritation tests
Lumi-Cell Endocrine Disruptor Test Validation Supported By ICCVAM
Animal alternative tests
ICCVAM/ECVAM Early Collaboration Explored To Hasten Animal Alternatives
ICCVAM/ECVAM Early Collaboration Explored To Hasten Animal Alternatives
Advertisement
UsernamePublicRestriction

Register

RS011989

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel